Monitoring Gesetzessammlung

Gesetze und Verordnungen USA alphabetisch

A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z
0 1 2 3 4 5 6 7 8 9
PART 209—REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT
21 CFR Part 209
PART 21—PROTECTION OF PRIVACY
21 CFR Part 21
PART 210—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL
21 CFR Part 210
PART 211—CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS
21 CFR Part 211
PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
21 CFR Part 212
PART 213—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICAL GASES
21 CFR Part 213
PART 216—HUMAN DRUG COMPOUNDING
21 CFR Part 216
PART 225—CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS
21 CFR Part 225
PART 226—CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES
21 CFR Part 226
PART 230—CERTIFICATION AND POSTMARKETING REPORTING FOR DESIGNATED MEDICAL GASES
21 CFR Part 230
PART 25—ENVIRONMENTAL IMPACT CONSIDERATIONS
21 CFR Part 25
PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
21 CFR Part 250
PART 251—SECTION 804 IMPORTATION PROGRAM
21 CFR Part 251
PART 290—CONTROLLED DRUGS
21 CFR Part 290
PART 299—DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES
21 CFR Part 299
PART 3—PRODUCT JURISDICTION
21 CFR Part 3
PART 300—GENERAL
21 CFR Part 300
PART 310—NEW DRUGS
21 CFR Part 310
PART 312—INVESTIGATIONAL NEW DRUG APPLICATION
21 CFR Part 312
PART 314—APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
21 CFR Part 314
Verwendung von Cookies.

Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

Akzeptieren
Markierungen
Leseansicht